Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2018

01-05-2018 | Original Article

Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure

Authors: V. Eskandari, A. A. Amirzargar, M. J. Mahmoudi, Z. Rahnemoon, F. Rahmani, S. Sadati, Z. Rahmati, F. Gorzin, M. Hedayat, N. Rezaei

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2018

Login to get access

Abstract

Background

Evidence shows that proinflammatory cytokines are important determinants of assessment of severity and prognosis of chronic heart failure (CHF).

Aims

We investigated whether peripheral expression of the proinflammmatory factors, TNF-α and IL-6 can predict variable of clinical assessment of patients with CHF.

Methods

In this report, we used real-time PCR assay to compare relative gene expression of TNFα and IL-6 in PBMC from CHF patients with various heart diseases (n = 42, EF < 45%, NYHA I to IV) and matched healthy control subjects (n = 42).We also determined the TNFα and IL-6 concentrations of cell culture supernatant of PBMCs with ELISA.

Results

There was a significant negative correlation between gene expression of TNFα and LVEF(r = 0.4, p < 0.05). Patients with CHF had increased gene expression of TNFα and IL-6 in PBMCs (p < 0.05). They also had elevated the supernatant levels of these cytokines in cultured PBMCs (p < 0.001). Levels of TNFα and IL-6 were increased in ischemic heart disease compared to non-ischemic heart disease. There was a positive correlation between TNFα and IL-6 levels in CHF patients and severity of CHF in patients. Levels of these cytokines were higher in patients with NYHA III–IV than in NYHA I–II and normal subjects.

Conclusions

Results of this study indicate that peripheral expression of proinflammatory cytokines, TNF-α and IL-6, is important indicators of severity and prognosis in patients with chronic heart disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sears SF et al (2013) A patient’s guide to living confidently with chronic heart failure. Circulation 127(13):e525–e528CrossRefPubMed Sears SF et al (2013) A patient’s guide to living confidently with chronic heart failure. Circulation 127(13):e525–e528CrossRefPubMed
2.
go back to reference King M, Kingery J, Baretta Casey M (2012) Diagnosis and evaluation of heart failure. Heart Failure 100(21):23 King M, Kingery J, Baretta Casey M (2012) Diagnosis and evaluation of heart failure. Heart Failure 100(21):23
3.
go back to reference Gullestad L et al (2012) Inflammatory cytokines in heart failure: mediators and markers. Cardiology 122(1):23–35CrossRefPubMed Gullestad L et al (2012) Inflammatory cytokines in heart failure: mediators and markers. Cardiology 122(1):23–35CrossRefPubMed
4.
go back to reference van Oeffelen AA et al (2014) Prognosis after a first hospitalisation for acute myocardial infarction and congestive heart failure by country of birth. Heart 100(18):1436–1443CrossRefPubMed van Oeffelen AA et al (2014) Prognosis after a first hospitalisation for acute myocardial infarction and congestive heart failure by country of birth. Heart 100(18):1436–1443CrossRefPubMed
5.
go back to reference Fedacko J et al (2014) Inflammatory mediators in chronic heart failure in north India. Acta Cardiol 69(4):391–398CrossRefPubMed Fedacko J et al (2014) Inflammatory mediators in chronic heart failure in north India. Acta Cardiol 69(4):391–398CrossRefPubMed
6.
go back to reference Dick SA, Epelman S (2016) Chronic heart failure and inflammation what do we really know? Circ Res 119(1):159–176CrossRefPubMed Dick SA, Epelman S (2016) Chronic heart failure and inflammation what do we really know? Circ Res 119(1):159–176CrossRefPubMed
7.
go back to reference Jug B et al (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessel 24(4):271–276CrossRef Jug B et al (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessel 24(4):271–276CrossRef
8.
go back to reference Tamariz L, Hare JM (2010) Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. Eur Heart J 31(7):768–770CrossRefPubMed Tamariz L, Hare JM (2010) Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. Eur Heart J 31(7):768–770CrossRefPubMed
9.
go back to reference Hedayat M et al (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15(6):543–562CrossRefPubMed Hedayat M et al (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15(6):543–562CrossRefPubMed
10.
go back to reference Oikonomou E et al (2011) The role of inflammation in heart failure: new therapeutic approaches. Hell J Cardiol 52(1):30–40 Oikonomou E et al (2011) The role of inflammation in heart failure: new therapeutic approaches. Hell J Cardiol 52(1):30–40
11.
go back to reference Kleinbongard P, Schulz R, Heusch G (2011) TNFα in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev 16(1):49–69CrossRefPubMed Kleinbongard P, Schulz R, Heusch G (2011) TNFα in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev 16(1):49–69CrossRefPubMed
12.
go back to reference Levine B et al (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236–241CrossRefPubMed Levine B et al (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236–241CrossRefPubMed
14.
go back to reference Deswal A et al (2001) Cytokines and cytokine receptors in advanced heart failure an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055–2059CrossRefPubMed Deswal A et al (2001) Cytokines and cytokine receptors in advanced heart failure an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055–2059CrossRefPubMed
15.
go back to reference Moro-Garcia MA et al (2014) Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease. Int J Cardiol 174(3):590–599CrossRefPubMed Moro-Garcia MA et al (2014) Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease. Int J Cardiol 174(3):590–599CrossRefPubMed
18.
go back to reference Laroumanie F et al (2014) CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129(21):2111–2124CrossRefPubMed Laroumanie F et al (2014) CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129(21):2111–2124CrossRefPubMed
20.
go back to reference Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108CrossRefPubMed Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108CrossRefPubMed
21.
go back to reference Nieminen MS et al (2015) The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol 191:256–264CrossRefPubMed Nieminen MS et al (2015) The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol 191:256–264CrossRefPubMed
22.
go back to reference Lee JO, Song R (2015) Symptom management to predict quality of life in patients with heart failure: a structural equation modeling approach. J Korean Acad Nurs 45(6):846–856CrossRefPubMed Lee JO, Song R (2015) Symptom management to predict quality of life in patients with heart failure: a structural equation modeling approach. J Korean Acad Nurs 45(6):846–856CrossRefPubMed
24.
go back to reference Bozkurt B, Mann DL, Deswal A (2010) Biomarkers of inflammation in heart failure. Heart Fail Rev 15(4):331–341CrossRefPubMed Bozkurt B, Mann DL, Deswal A (2010) Biomarkers of inflammation in heart failure. Heart Fail Rev 15(4):331–341CrossRefPubMed
26.
go back to reference Aukrust P et al (1998) Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97(12):1136CrossRefPubMed Aukrust P et al (1998) Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97(12):1136CrossRefPubMed
27.
28.
go back to reference Zhu J et al (2006) TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 34(1–2):96–105CrossRefPubMed Zhu J et al (2006) TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 34(1–2):96–105CrossRefPubMed
29.
go back to reference Wu J et al (2016) Intermittent hypoxia causes inflammation and injury to human adult cardiac myocytes. Anesth Analg 122(2):373–380CrossRefPubMed Wu J et al (2016) Intermittent hypoxia causes inflammation and injury to human adult cardiac myocytes. Anesth Analg 122(2):373–380CrossRefPubMed
30.
31.
go back to reference Zhang HF et al (2012) Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress. J Transl Med 10:120CrossRefPubMedPubMedCentral Zhang HF et al (2012) Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress. J Transl Med 10:120CrossRefPubMedPubMedCentral
32.
go back to reference Wojtczak-Soska K et al (2014) Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure. Kardiol Pol 72(8):725–734CrossRefPubMed Wojtczak-Soska K et al (2014) Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure. Kardiol Pol 72(8):725–734CrossRefPubMed
33.
go back to reference Ueland T et al (2015) Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta 443:71–77CrossRefPubMed Ueland T et al (2015) Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta 443:71–77CrossRefPubMed
34.
go back to reference Hartupee J, Mann DL (2013) Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res 6(4):485–492CrossRefPubMed Hartupee J, Mann DL (2013) Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res 6(4):485–492CrossRefPubMed
35.
go back to reference Anker SD et al (1997) Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79(10):1426–1430CrossRefPubMed Anker SD et al (1997) Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79(10):1426–1430CrossRefPubMed
36.
go back to reference Love VA et al (2007) CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res 101(3):248–257CrossRefPubMed Love VA et al (2007) CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res 101(3):248–257CrossRefPubMed
38.
go back to reference Deliargyris EN et al (2000) Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 86(9):913–918CrossRefPubMed Deliargyris EN et al (2000) Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 86(9):913–918CrossRefPubMed
39.
go back to reference Satoh S et al (2006) Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure. Int J Cardiol 111(3):405–412CrossRefPubMed Satoh S et al (2006) Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure. Int J Cardiol 111(3):405–412CrossRefPubMed
40.
go back to reference Yndestad A et al (2002) Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 54(1):175–182CrossRefPubMed Yndestad A et al (2002) Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 54(1):175–182CrossRefPubMed
41.
go back to reference Deswal A et al (1999) Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99(25):3224–3226CrossRefPubMed Deswal A et al (1999) Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99(25):3224–3226CrossRefPubMed
42.
go back to reference Mann DL et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109(13):1594–1602CrossRefPubMed Mann DL et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109(13):1594–1602CrossRefPubMed
43.
go back to reference Chung ES et al (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107(25):3133–3140CrossRefPubMed Chung ES et al (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107(25):3133–3140CrossRefPubMed
44.
go back to reference McTiernan CF et al (2012) The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure. Cytokine 60(3):838–842CrossRefPubMedPubMedCentral McTiernan CF et al (2012) The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure. Cytokine 60(3):838–842CrossRefPubMedPubMedCentral
45.
go back to reference Zhao S-P, Xu T-D (1999) Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure. Int J Cardiol 71(3):257–261CrossRefPubMed Zhao S-P, Xu T-D (1999) Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure. Int J Cardiol 71(3):257–261CrossRefPubMed
46.
go back to reference Sharma R et al (2005) Cellular endotoxin desensitization in patients with severe chronic heart failure. Eur J Heart Fail 7(5):865–868CrossRefPubMed Sharma R et al (2005) Cellular endotoxin desensitization in patients with severe chronic heart failure. Eur J Heart Fail 7(5):865–868CrossRefPubMed
47.
48.
go back to reference Papadimitriou L, Kalogeropoulos AP (2015) Inflammatory biomarkers and therapeutic targets in heart failure. Curr Med Chem 22(23):2716–2726CrossRefPubMed Papadimitriou L, Kalogeropoulos AP (2015) Inflammatory biomarkers and therapeutic targets in heart failure. Curr Med Chem 22(23):2716–2726CrossRefPubMed
49.
go back to reference Kalogeropoulos A et al (2010) Inflammatory markers and incident heart failure risk in older adults: the health ABC (health, aging, and body composition) study. J Am Coll Cardiol 55(19):2129–2137CrossRefPubMedPubMedCentral Kalogeropoulos A et al (2010) Inflammatory markers and incident heart failure risk in older adults: the health ABC (health, aging, and body composition) study. J Am Coll Cardiol 55(19):2129–2137CrossRefPubMedPubMedCentral
50.
go back to reference Latini R et al (2012) Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. Eur J Heart Fail 14(9):992–999CrossRefPubMed Latini R et al (2012) Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. Eur J Heart Fail 14(9):992–999CrossRefPubMed
51.
go back to reference Manzano-Fernandez S et al (2011) Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol 107(2):259–267CrossRefPubMedPubMedCentral Manzano-Fernandez S et al (2011) Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol 107(2):259–267CrossRefPubMedPubMedCentral
52.
go back to reference Shimokawa H, Kuroiwa-Matsumoto M, Takeshita A (1998) Cytokine generation capacities of monocytes are reduced in patients with severe heart failure. Am Heart J 136(6):991–1002CrossRefPubMed Shimokawa H, Kuroiwa-Matsumoto M, Takeshita A (1998) Cytokine generation capacities of monocytes are reduced in patients with severe heart failure. Am Heart J 136(6):991–1002CrossRefPubMed
53.
go back to reference Satoh M et al (2004) Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail 6(7):869–875CrossRefPubMed Satoh M et al (2004) Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail 6(7):869–875CrossRefPubMed
Metadata
Title
Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure
Authors
V. Eskandari
A. A. Amirzargar
M. J. Mahmoudi
Z. Rahnemoon
F. Rahmani
S. Sadati
Z. Rahmati
F. Gorzin
M. Hedayat
N. Rezaei
Publication date
01-05-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1680-2

Other articles of this Issue 2/2018

Irish Journal of Medical Science (1971 -) 2/2018 Go to the issue